Global market for cardiovascular sector worth $139.8 billion by 2015

The overall cardiovascular sector grew to $140.7 billion in 2009, showing a growth rate of 3.1% and is expected to continue to grow in 2010 to $144.5 billion by a compound annual growth rate (CAGR) of 2.7%. The sector will experience a sizable reduction in the early portion of the forecast period, and then slowly rise to a net small reduction by 2015 on a CAGR basis of -0.7%, to a figure of $139.8 billion.

Learn about the overall industry trends in the global market for cardiovascular therapies with current and projected product forecasts through 2015; get detailed product analyses within disease subsegments and an analysis of leading and emerging competitors in this field with relevant company profiles...

Use this report to:

• Identify and understand overall market trends in cardiovascular therapeutics, including emerging geographies, M&A opportunities, and insights that provide guidance for sales growth or defensive moves
• Develop effective strategies to take advantage of product opportunities in this dynamic market as combination and differentiated therapies influence the competitive environment, and key products lose patent protection
• Validate internal marketing and business development plans with quantitative and qualitative forecasts by product, product category, and by company from 2009 through 2015
• Learn about leading and novel products in each core segment of the overall market, their specific mechanisms of action, and their competitive positions.

To provide further information about this report we offer a Complimentary Introduction, available from our Website.